Ranked by engagement
Top topics — all time page 22
Ranked by replies, likes and views over all time, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.
1,535 topics · page 22 of 40
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Coming back to: Private prescribing in the UK: what is actually involved
Private prescribing in the UK: what is actually involved Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included, since that…
|
+62 | 67 | 2.1k | 6mo |
|
Gastro-oesophageal reflux: improving or worsening?
The question in the title: Gastro-oesophageal reflux: improving or worsening? I will give what I have already checked below so nobody repeats it. Asking about a population rather than about a person. The…
|
+54 | 58 | 8.2k | 1mo |
|
Journal club: SURMOUNT-4 and continuation versus withdrawal
Journal club: SURMOUNT-4 and continuation versus withdrawal — setting out what I have, and where I think it stops being reliable. I have seen FLOW ( N Engl J Med , 2024) cited in support of a claim I do not…
|
+32 | 36 | 31k | 3mo |
|
Coming back to: Preparing for an appointment: one page, three questions
Preparing for an appointment: one page, three questions — setting out what I have, and where I think it stops being reliable. General question, not a request for advice about my own care — I know the…
|
+51 | 56 | 1.4k | 2d |
|
Specificity, linearity, accuracy, precision, range, robustness — with real criteria
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Writing it up because I had to work it out twice and would rather nobody else did. I would like to understand what this…
|
+44 | 48 | 12k | 1d |
|
IGF-1 as a surrogate endpoint and its limitations — the long version
On the subject in the title: IGF-1 as a surrogate endpoint and its limitations — the long version Working notes rather than a conclusion. I have seen STEP 2 ( Lancet , 2021) cited in support of a claim I do…
|
+14 | 18 | 53k | 12mo |
|
Discussing something you have already been doing — the long version
Discussing something you have already been doing — the long version Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The…
|
+14 | 18 | 58k | 12mo |
|
Travel coolers and how long they really hold — the long version
Travel coolers and how long they really hold — the long version — setting out what I have, and where I think it stops being reliable. Reporting something rather than asking about it, in case the pattern is…
|
+19 | 23 | 45k | 14mo |
|
Gauge and length selection for subcutaneous injection
Gauge and length selection for subcutaneous injection Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units stated, because I have seen how…
|
+50 | 55 | 1.3k | 8mo |
|
Interim analyses and stopping rules — does this still hold?
Interim analyses and stopping rules — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Comparing SCALE ( N Engl J Med , 2015) with SURMOUNT-4 (…
|
+30 | 34 | 29k | 13mo |
|
Food noise reducing and the disorientation that can follow
Posting this under the heading it deserves: Food noise reducing and the disorientation that can follow Everything below is what sits behind that. General question, not a request for advice about my own care —…
|
+40 | 45 | 8.9k | 20mo |
|
[2026 update] Amylin and gastric emptying: overlapping mechanisms with incretins
Amylin and gastric emptying: overlapping mechanisms with incretins — setting out what I have, and where I think it stops being reliable. Session topic: FLOW ( N Engl J Med , 2024). Please read it before…
|
+21 | 25 | 44k | 5mo |
|
Second pass at: Gauge and length selection for subcutaneous injection
Posting this under the heading it deserves: Second pass at: Gauge and length selection for subcutaneous injection Everything below is what sits behind that. A question about technique rather than about dose.…
|
+50 | 58 | 14k | 15mo |
|
Tracking that stops updating and then resumes
On the subject in the title: Tracking that stops updating and then resumes Working notes rather than a conclusion. A logistics question, since the answers here are usually better than anywhere else I have…
|
+58 | 62 | 1.9k | 7mo |
|
[2026 update] Long-time reader, first-time poster
Long-time reader, first-time poster — setting out what I have, and where I think it stops being reliable. Lower-stakes topic, but the sourcing rule still applies if anyone makes a claim. Something adjacent…
|
+46 | 50 | 23k | 5mo |
|
How much fluid is actually needed, and how you would know
The question in the title: How much fluid is actually needed, and how you would know I will give what I have already checked below so nobody repeats it. Maintenance rather than loss, which is the part of this…
|
+11 | 15 | 53k | 2mo |
|
Ipamorelin selectivity claims and where they came from
Ipamorelin selectivity claims and where they came from — setting out what I have, and where I think it stops being reliable. I have seen LEADER ( N Engl J Med , 2016) cited in support of a claim I do not…
|
+51 | 56 | 8.8k | 12mo |
|
Reading SURMOUNT-1 without the press release — one year on
Reading SURMOUNT-1 without the press release — one year on — setting out what I have, and where I think it stops being reliable. I have seen LEADER ( N Engl J Med , 2016) cited in support of a claim I do not…
|
+45 | 50 | 7.6k | 5mo |
|
[2026 update] A single out-of-range value on an otherwise normal panel
On the subject in the title: A single out-of-range value on an otherwise normal panel Working notes rather than a conclusion. General question, not a request for advice about my own care — I know the…
|
+15 | 19 | 53k | 9mo |
|
Oral versus injected administration claims for BPC-157
Oral versus injected administration claims for BPC-157 — setting out what I have, and where I think it stops being reliable. I have seen FLOW ( N Engl J Med , 2024) cited in support of a claim I do not think…
|
+20 | 24 | 47k | 4mo |
|
[2026 update] Lipid changes during rapid weight loss: the expected trajectory
Lipid changes during rapid weight loss: the expected trajectory Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The…
|
+51 | 56 | 7.1k | 17mo |
|
[2026 update] Availability by country, dated, with primary sources
On the subject in the title: Availability by country, dated, with primary sources Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires. As…
|
+40 | 45 | 14k | 4mo |
|
Prediction intervals and why they are more honest than confidence intervals
Posting this under the heading it deserves: Prediction intervals and why they are more honest than confidence intervals Everything below is what sits behind that. Comparing SURMOUNT-4 ( JAMA , 2024) with FLOW…
|
+21 | 25 | 46k | 4mo |
|
Follow-up: Constipation management, with a dietitian's contribution
Constipation management, with a dietitian's contribution — setting out what I have, and where I think it stops being reliable. A question about technique rather than about dose. I have been doing the same…
|
+31 | 35 | 28k | 8mo |
|
Coming back to: Where the four-week escalation interval comes from, and what it is not
Posting this under the heading it deserves: Where the four-week escalation interval comes from, and what it is not Everything below is what sits behind that. I have read the maintained page on this and I…
|
+44 | 48 | 11k | 1d |
|
A certificate with no method stated: what can you conclude?
A certificate with no method stated: what can you conclude? I have a specific reason for asking rather than idle curiosity, and the context is below. I would like to understand what this number means before I…
|
+49 | 57 | 1.2k | 16mo |
|
Coming back to: Solubility limits and what a cloudy solution is telling you
On the subject in the title: Solubility limits and what a cloudy solution is telling you Working notes rather than a conclusion. A documentation question rather than an analytical one. I have a certificate in…
|
+38 | 43 | 29k | 13h |
|
High-resolution MS on aggregates and what it can see — one year on
High-resolution MS on aggregates and what it can see — one year on Writing it up because I had to work it out twice and would rather nobody else did. Working through the identity arithmetic and I would like…
|
+54 | 58 | 1.2k | 23mo |
|
Which categories are strict and which are relaxed, honestly
Which categories are strict and which are relaxed, honestly I have a specific reason for asking rather than idle curiosity, and the context is below. I want to check my reasoning rather than get a conclusion.…
|
+47 | 53 | 1.8k | 2d |
|
What I would want from a home test that does not exist yet
The question in the title: What I would want from a home test that does not exist yet I will give what I have already checked below so nobody repeats it. A documentation question rather than an analytical…
|
+46 | 50 | 8k | 6h |